Bezafibrate
is an agonist of peroxisome proliferator-activated receptor alpha (PPARalpha)
with antilipidemic activity. Bezafibrate decreases triglyceride levels,
increases top body lipoprotein (HDL) cholesterol levels, and decreases absolute
and low body lipoprotein (LDL) cholesterol levels.
Bezafibrate
is alone begin in individuals that accept acclimated or taken this drug. It is
an antilipemic abettor that lowers cholesterol and triglycerides. It decreases
low body lipoproteins and increases top body lipoproteins.Like the added
fibrates, bezafibrate is an agonist of PPAR& alpha; ; some studies advance
it may accept some action on PPAR& gamma; and PPAR& delta; as well.

No comments:
Post a Comment